239 related articles for article (PubMed ID: 23542176)
1. Pin1 modulates ERα levels in breast cancer through inhibition of phosphorylation-dependent ubiquitination and degradation.
Rajbhandari P; Schalper KA; Solodin NM; Ellison-Zelski SJ; Ping Lu K; Rimm DL; Alarid ET
Oncogene; 2014 Mar; 33(11):1438-47. PubMed ID: 23542176
[TBL] [Abstract][Full Text] [Related]
2. Regulation of estrogen receptor α N-terminus conformation and function by peptidyl prolyl isomerase Pin1.
Rajbhandari P; Finn G; Solodin NM; Singarapu KK; Sahu SC; Markley JL; Kadunc KJ; Ellison-Zelski SJ; Kariagina A; Haslam SZ; Lu KP; Alarid ET
Mol Cell Biol; 2012 Jan; 32(2):445-57. PubMed ID: 22064478
[TBL] [Abstract][Full Text] [Related]
3. Peptidylprolyl Isomerase Pin1 Directly Enhances the DNA Binding Functions of Estrogen Receptor α.
Rajbhandari P; Ozers MS; Solodin NM; Warren CL; Alarid ET
J Biol Chem; 2015 May; 290(22):13749-62. PubMed ID: 25866209
[TBL] [Abstract][Full Text] [Related]
4. The prolyl isomerase Pin1 acts synergistically with CDK2 to regulate the basal activity of estrogen receptor α in breast cancer.
Lucchetti C; Caligiuri I; Toffoli G; Giordano A; Rizzolio F
PLoS One; 2013; 8(2):e55355. PubMed ID: 23390529
[TBL] [Abstract][Full Text] [Related]
5. Prolyl isomerase Pin1 downregulates tumor suppressor RUNX3 in breast cancer.
Nicole Tsang YH; Wu XW; Lim JS; Wee Ong C; Salto-Tellez M; Ito K; Ito Y; Chen LF
Oncogene; 2013 Mar; 32(12):1488-96. PubMed ID: 22580604
[TBL] [Abstract][Full Text] [Related]
6. Proyl isomerase Pin1 facilitates ubiquitin-mediated degradation of cyclin-dependent kinase 10 to induce tamoxifen resistance in breast cancer cells.
Khanal P; Yun HJ; Lim SC; Ahn SG; Yoon HE; Kang KW; Hong R; Choi HS
Oncogene; 2012 Aug; 31(34):3845-56. PubMed ID: 22158035
[TBL] [Abstract][Full Text] [Related]
7. Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 directly binds and stabilizes Nrf2 in breast cancer.
Saeidi S; Kim SJ; Guillen-Quispe YN; Jagadeesh ASV; Han HJ; Kim SH; Zhong X; Piao JY; Kim SJ; Jeong J; Shin YJ; Cha YJ; Lee HB; Han W; Min SH; Tian W; Kitamura H; Surh YJ
FASEB J; 2022 Jan; 36(1):e22068. PubMed ID: 34918396
[TBL] [Abstract][Full Text] [Related]
8. Prolyl isomerase Pin1 negatively regulates the stability of SUV39H1 to promote tumorigenesis in breast cancer.
Khanal P; Kim G; Lim SC; Yun HJ; Lee KY; Choi HK; Choi HS
FASEB J; 2013 Nov; 27(11):4606-18. PubMed ID: 23934277
[TBL] [Abstract][Full Text] [Related]
9. Pin1-Catalyzed Conformation Changes Regulate Protein Ubiquitination and Degradation.
Jeong J; Usman M; Li Y; Zhou XZ; Lu KP
Cells; 2024 Apr; 13(9):. PubMed ID: 38727267
[TBL] [Abstract][Full Text] [Related]
10. Prolyl isomerase Pin1 is highly expressed in Her2-positive breast cancer and regulates erbB2 protein stability.
Lam PB; Burga LN; Wu BP; Hofstatter EW; Lu KP; Wulf GM
Mol Cancer; 2008 Dec; 7():91. PubMed ID: 19077306
[TBL] [Abstract][Full Text] [Related]
11. A critical step for JNK activation: isomerization by the prolyl isomerase Pin1.
Park JE; Lee JA; Park SG; Lee DH; Kim SJ; Kim HJ; Uchida C; Uchida T; Park BC; Cho S
Cell Death Differ; 2012 Jan; 19(1):153-61. PubMed ID: 21660049
[TBL] [Abstract][Full Text] [Related]
12. Prolyl isomerase Pin1 acts as a switch to control the degree of substrate ubiquitylation.
Siepe D; Jentsch S
Nat Cell Biol; 2009 Aug; 11(8):967-72. PubMed ID: 19597489
[TBL] [Abstract][Full Text] [Related]
13. COT phosphorylates prolyl-isomerase Pin1 to promote tumorigenesis in breast cancer.
Kim G; Khanal P; Kim JY; Yun HJ; Lim SC; Shim JH; Choi HS
Mol Carcinog; 2015 Jun; 54(6):440-8. PubMed ID: 24265246
[TBL] [Abstract][Full Text] [Related]
14. Prolyl isomerase Pin1 enhances osteoblast differentiation through Runx2 regulation.
Lee SH; Choi YH; Kim YJ; Choi HS; Yeo CY; Lee KY
FEBS Lett; 2013 Nov; 587(22):3640-7. PubMed ID: 24113655
[TBL] [Abstract][Full Text] [Related]
15. The prolyl isomerase Pin1 induces LC-3 expression and mediates tamoxifen resistance in breast cancer.
Namgoong GM; Khanal P; Cho HG; Lim SC; Oh YK; Kang BS; Shim JH; Yoo JC; Choi HS
J Biol Chem; 2010 Jul; 285(31):23829-41. PubMed ID: 20479004
[TBL] [Abstract][Full Text] [Related]
16. Prolyl isomerase Pin1 regulates cadmium-induced autophagy via ubiquitin-mediated post-translational stabilization of phospho-Ser GSK3αβ in human hepatocellular carcinoma cells.
So KY; Oh SH
Biochem Pharmacol; 2015 Dec; 98(3):511-21. PubMed ID: 26445356
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylation-specific peptidyl-prolyl isomerization of neuronal cytoskeletal proteins by Pin1: implications for therapeutics in neurodegeneration.
Rudrabhatla P; Pant HC
J Alzheimers Dis; 2010; 19(2):389-403. PubMed ID: 20110589
[TBL] [Abstract][Full Text] [Related]
18. The GPER1/SPOP axis mediates ubiquitination-dependent degradation of ERα to inhibit the growth of breast cancer induced by oestrogen.
Zhang N; Sun P; Xu Y; Li H; Liu H; Wang L; Cao Y; Zhou K; TinghuaiWang
Cancer Lett; 2021 Feb; 498():54-69. PubMed ID: 33069770
[TBL] [Abstract][Full Text] [Related]
19. The peptidyl-isomerase Pin1 regulates p27kip1 expression through inhibition of Forkhead box O tumor suppressors.
Brenkman AB; de Keizer PL; van den Broek NJ; van der Groep P; van Diest PJ; van der Horst A; Smits AM; Burgering BM
Cancer Res; 2008 Sep; 68(18):7597-605. PubMed ID: 18794148
[TBL] [Abstract][Full Text] [Related]
20. The prolyl isomerase Pin1 enhances HER-2 expression and cellular transformation via its interaction with mitogen-activated protein kinase/extracellular signal-regulated kinase kinase 1.
Khanal P; Namgoong GM; Kang BS; Woo ER; Choi HS
Mol Cancer Ther; 2010 Mar; 9(3):606-16. PubMed ID: 20179161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
